Agency Forms Undergoing Paperwork Reduction Act Review, 64472-64473 [2020-22487]
Download as PDF
64472
Federal Register / Vol. 85, No. 198 / Tuesday, October 13, 2020 / Notices
of case notification data for
Blastomycosis and disease-specific data
elements for CO Poisoning, Congenital
Syphilis, and Sexually Transmitted
Disease (not congenital). The estimated
annual burden for the 257 respondents
is 18,354 hours. The total burden hours
increased from 18,414 to 18,954 since
the last revision due to an increase in
diseases and disease-specific data
elements added in this revision as
compared to the last revision.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
States
States
States
States
States
.............................
.............................
.............................
.............................
.............................
Territories
Territories
Territories
Territories
Territories
.......................
.......................
.......................
.......................
.......................
Freely
Freely
Freely
Freely
Associated
Associated
Associated
Associated
States
States
States
States
Cities
Cities
Cities
Cities
Cities
..............................
..............................
..............................
..............................
..............................
Total ........................
Total burden
(in hours)
50
10
50
50
50
52
52
52
1
1
20/60
2
4
75
2
867
1,040
10,400
3,750
100
5
5
5
5
5
52
56
52
1
1
20/60
20/60
4
5
2
87
93
1,040
25
10
3
3
3
3
52
56
1
1
20/60
20/60
5
2
52
56
15
6
2
2
2
2
2
52
52
52
1
1
20/60
2
4
75
2
35
208
416
150
4
..............................................................................
........................
........................
........................
18,954
[FR Doc. 2020–22490 Filed 10–9–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–21–0109]
Agency Forms Undergoing Paperwork
Reduction Act Review
khammond on DSKJM1Z7X2PROD with NOTICES
Average
burden per
response
(in hours)
Weekly (Automated) ............................................
Weekly (Non-automated) .....................................
Weekly (NMI Implementation) .............................
Annual ..................................................................
One-time Addition of Diseases and Data Elements.
Weekly (Automated) ............................................
Weekly, Quarterly (Non-automated) ....................
Weekly (NMI Implementation) .............................
Annual ..................................................................
One-time Addition of Diseases and Data Elements.
Weekly (Automated) ............................................
Weekly, Quarterly (Non-automated) ....................
Annual ..................................................................
One-time Addition of Diseases and Data Elements.
Weekly (Automated) ............................................
Weekly (Non-automated) .....................................
Weekly (NMI Implementation) .............................
Annual ..................................................................
One-time Addition of Diseases and Data Elements.
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Respiratory
Protective Devices—42 CFR 84—
Regulation to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on July 20,
2020 to obtain comments from the
public and affected agencies. CDC did
not receive comments related to the
VerDate Sep<11>2014
Number of
responses per
respondent
Number of
respondents
Form name
18:52 Oct 09, 2020
Jkt 253001
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Respiratory Protective Devices—42
CFR part 84—Regulation (OMB Control
No. 0920–0109, Exp. 10/31/2020) —
Revision — National Institute for
Occupational Safety and Health
(NIOSH), Centers for Disease Control
and Prevention (CDC).
E:\FR\FM\13OCN1.SGM
13OCN1
64473
Federal Register / Vol. 85, No. 198 / Tuesday, October 13, 2020 / Notices
Background and Brief Description
The regulatory authority for the
National Institute for Occupational
Safety and Health (NIOSH) certification
program for respiratory protective
devices is found in the Mine Safety and
Health Amendments Act of 1977 (30
U.S.C. 577a, 651 et seq., and 657(g)) and
the Occupational Safety and Health Act
of 1970 (30 U.S.C. 3, 5, 7, 811, 842(h),
844). These regulations have, as their
basis, the performance tests and criteria
for approval of respirators used by
millions of American construction
workers, miners, painters, asbestos
removal workers, fabric mill workers,
and fire fighters.
Regulations of the Environmental
Protection Agency (EPA) and the
Nuclear Regulatory Commission (NRC)
also require the use of NIOSH-approved
respirators. These regulations also
establish methods for respirator
manufacturers to submit respirators for
testing under the regulation and have
them certified as NIOSH-approved if
they meet the criteria given in the above
regulation. This data collection was
formerly named Respiratory Protective
Devices 30 CFR part 11 but in 1995, the
respirator standard was moved to 42
CFR part 84.
NIOSH, in accordance with 42 CFR
part 84: (1) Issues certificates of
approval for respirators which have met
specified construction, performance,
and protection requirements; (2)
establishes procedures and
requirements to be met in filing
applications for approval; (3) specifies
minimum requirements and methods to
be employed by NIOSH and by
applicants in conducting inspections,
examinations, and tests to determine
effectiveness of respirators; (4)
establishes a schedule of fees to be
charged applicants for testing and
certification, and (5) establishes
approval labeling requirements.
Information is collected from those who
request services under 42 CFR part 84
in order to properly establish the scope
and intent of request.
Information collected from requests
for respirator approval functions
includes contact information and
information about factors likely to affect
respirator performance and use. Such
information includes, but is not
necessarily limited to, respirator design,
manufacturing methods and materials,
quality assurance plans and procedures,
and user instruction and draft labels, as
specified in the regulation.
The main instrument for data
collection for respirator approval
functions is the Standard Application
Form for the Approval of Respirators
(SAF) (currently Version 9). Respirator
manufacturers are the respondents
(estimated to average 140 each year over
the years 2020–2023) and upon
completion of the SAF their requests for
approval are evaluated. A total of 375
applications were submitted in CY2019.
To date, 300 applications have been
submitted in CY2020. The increased
submission rate is due to the
publication of a new respirator class,
PAPR100, as well certification requests
due to COVID 19. No survey was
conducted to more thoroughly analyze
the reasons for the change in number of
respondents. The applications are
submitted at will and taking into
account both historical conditions and
as well as the current situation, our
prediction of the number of respondents
each year between CY2020 and CY2022
is 140. A $200 fee is required for each
application. Respondents requesting
respirator approval or certain extensions
of approval are required to submit
additional fees for necessary testing and
evaluation as specified in 42 CFR parts
84.20–22, 84.66, 84.258 and 84.1102.
Applicants are required to provide
test data that shows that the
manufacturer is capable of ensuring that
the respirator is capable of meeting the
specified requirements in 42 CFR part
84. The requirement for submitted test
data is likely to be satisfied by standard
testing performed by the manufacturer,
and is not required to follow the
relevant NIOSH Standard Test
Procedures. As additional testing is not
required, providing proof that an
adequate test has been performed is
limited to providing existing paperwork.
42 CFR part 84 approvals offer
corroboration that approved respirators
are produced to certain quality
standards. Although 42 CFR part 84
Subpart E prescribes certain quality
standards, it is not expected that
requiring approved quality standards
will impose an additional cost burden
over similarly effective quality
standards that are not approved under
42 CFR part 84.
Manufacturers with current approvals
are subject to site audits by the Institute
or its agents. Audits may occur
periodically, typically every second
year, or as a result of a reported issue.
Sixty-four site audits from 90 respirator
approval holders were scheduled for the
2020 fiscal year. There is an average fee
of $12,656 for each audit to align with
fee collection provisions of the
Independent Offices Appropriations Act
of 1952 (31 U.S.C. 9701), and OMB
Circular A–25 Revised. It is estimated
that the average over the next three
years (FY21–FY23) will be seventy. The
total estimated burden hours are
129,920.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Business or other for-profit .............................
Standard Application Form for the Approval
of Respirators.
Audit ...............................................................
Business or other for-profit .............................
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
respondents
Type of respondents
4
229
70
1
24
[FR Doc. 2020–22487 Filed 10–9–20; 8:45 am]
BILLING CODE 4163–18–P
18:52 Oct 09, 2020
Jkt 253001
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
E:\FR\FM\13OCN1.SGM
Average
burden per
response
(in hours)
140
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
VerDate Sep<11>2014
Number of
responses per
respondent
13OCN1
Agencies
[Federal Register Volume 85, Number 198 (Tuesday, October 13, 2020)]
[Notices]
[Pages 64472-64473]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-22487]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-21-0109]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Respiratory Protective Devices--42 CFR 84--
Regulation to the Office of Management and Budget (OMB) for review and
approval. CDC previously published a ``Proposed Data Collection
Submitted for Public Comment and Recommendations'' notice on July 20,
2020 to obtain comments from the public and affected agencies. CDC did
not receive comments related to the previous notice. This notice serves
to allow an additional 30 days for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Respiratory Protective Devices--42 CFR part 84--Regulation (OMB
Control No. 0920-0109, Exp. 10/31/2020) -- Revision -- National
Institute for Occupational Safety and Health (NIOSH), Centers for
Disease Control and Prevention (CDC).
[[Page 64473]]
Background and Brief Description
The regulatory authority for the National Institute for
Occupational Safety and Health (NIOSH) certification program for
respiratory protective devices is found in the Mine Safety and Health
Amendments Act of 1977 (30 U.S.C. 577a, 651 et seq., and 657(g)) and
the Occupational Safety and Health Act of 1970 (30 U.S.C. 3, 5, 7, 811,
842(h), 844). These regulations have, as their basis, the performance
tests and criteria for approval of respirators used by millions of
American construction workers, miners, painters, asbestos removal
workers, fabric mill workers, and fire fighters.
Regulations of the Environmental Protection Agency (EPA) and the
Nuclear Regulatory Commission (NRC) also require the use of NIOSH-
approved respirators. These regulations also establish methods for
respirator manufacturers to submit respirators for testing under the
regulation and have them certified as NIOSH-approved if they meet the
criteria given in the above regulation. This data collection was
formerly named Respiratory Protective Devices 30 CFR part 11 but in
1995, the respirator standard was moved to 42 CFR part 84.
NIOSH, in accordance with 42 CFR part 84: (1) Issues certificates
of approval for respirators which have met specified construction,
performance, and protection requirements; (2) establishes procedures
and requirements to be met in filing applications for approval; (3)
specifies minimum requirements and methods to be employed by NIOSH and
by applicants in conducting inspections, examinations, and tests to
determine effectiveness of respirators; (4) establishes a schedule of
fees to be charged applicants for testing and certification, and (5)
establishes approval labeling requirements. Information is collected
from those who request services under 42 CFR part 84 in order to
properly establish the scope and intent of request.
Information collected from requests for respirator approval
functions includes contact information and information about factors
likely to affect respirator performance and use. Such information
includes, but is not necessarily limited to, respirator design,
manufacturing methods and materials, quality assurance plans and
procedures, and user instruction and draft labels, as specified in the
regulation.
The main instrument for data collection for respirator approval
functions is the Standard Application Form for the Approval of
Respirators (SAF) (currently Version 9). Respirator manufacturers are
the respondents (estimated to average 140 each year over the years
2020-2023) and upon completion of the SAF their requests for approval
are evaluated. A total of 375 applications were submitted in CY2019. To
date, 300 applications have been submitted in CY2020. The increased
submission rate is due to the publication of a new respirator class,
PAPR100, as well certification requests due to COVID 19. No survey was
conducted to more thoroughly analyze the reasons for the change in
number of respondents. The applications are submitted at will and
taking into account both historical conditions and as well as the
current situation, our prediction of the number of respondents each
year between CY2020 and CY2022 is 140. A $200 fee is required for each
application. Respondents requesting respirator approval or certain
extensions of approval are required to submit additional fees for
necessary testing and evaluation as specified in 42 CFR parts 84.20-22,
84.66, 84.258 and 84.1102.
Applicants are required to provide test data that shows that the
manufacturer is capable of ensuring that the respirator is capable of
meeting the specified requirements in 42 CFR part 84. The requirement
for submitted test data is likely to be satisfied by standard testing
performed by the manufacturer, and is not required to follow the
relevant NIOSH Standard Test Procedures. As additional testing is not
required, providing proof that an adequate test has been performed is
limited to providing existing paperwork.
42 CFR part 84 approvals offer corroboration that approved
respirators are produced to certain quality standards. Although 42 CFR
part 84 Subpart E prescribes certain quality standards, it is not
expected that requiring approved quality standards will impose an
additional cost burden over similarly effective quality standards that
are not approved under 42 CFR part 84.
Manufacturers with current approvals are subject to site audits by
the Institute or its agents. Audits may occur periodically, typically
every second year, or as a result of a reported issue. Sixty-four site
audits from 90 respirator approval holders were scheduled for the 2020
fiscal year. There is an average fee of $12,656 for each audit to align
with fee collection provisions of the Independent Offices
Appropriations Act of 1952 (31 U.S.C. 9701), and OMB Circular A-25
Revised. It is estimated that the average over the next three years
(FY21-FY23) will be seventy. The total estimated burden hours are
129,920.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Business or other for-profit....... Standard Application Form 140 4 229
for the Approval of
Respirators.
Business or other for-profit....... Audit...................... 70 1 24
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2020-22487 Filed 10-9-20; 8:45 am]
BILLING CODE 4163-18-P